XBiotech Inc - ESG Rating & Company Profile powered by AI
This webpage includes a questions and answers table for XBiotech Inc. The SDG score for XBiotech Inc represents the company's reporting of the UN Sustainable Development Goals. If you are employed by XBiotech Inc and you wish to licence your ESG aseessment, please contact us.
XBiotech Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.1; made up of an environmental score of 0.0, social score of 0.0 and governance score of 3.2.
1.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1779 | Taisho Pharmaceutical Holdings Co Ltd | 1.2 | Low |
| 1779 | VBI Vaccines Inc | 1.2 | Low |
| 1810 | XBiotech Inc | 1.1 | Low |
| 1810 | Captor Capital Corp | 1.1 | Low |
| 1810 | Century Therapeutics Inc | 1.1 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does XBiotech Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes XBiotech Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes XBiotech Inc report the average age of the workforce?
Sign up for free to unlockDoes XBiotech Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes XBiotech Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes XBiotech Inc disclose cybersecurity risks?
Sign up for free to unlockDoes XBiotech Inc offer flexible work?
Sign up for free to unlockDoes XBiotech Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes XBiotech Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes XBiotech Inc conduct supply chain audits?
Sign up for free to unlockDoes XBiotech Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes XBiotech Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes XBiotech Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes XBiotech Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes XBiotech Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes XBiotech Inc disclose water use targets?
Sign up for free to unlockDoes XBiotech Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid XBiotech Inc have a product recall in the last two years?
Sign up for free to unlockDoes XBiotech Inc disclose incidents of discrimination?
Sign up for free to unlockDoes XBiotech Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas XBiotech Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes XBiotech Inc disclose parental leave metrics?
Sign up for free to unlockDoes XBiotech Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes XBiotech Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes XBiotech Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes XBiotech Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes XBiotech Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes XBiotech Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs XBiotech Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes XBiotech Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes XBiotech Inc disclose its waste policy?
Sign up for free to unlockDoes XBiotech Inc report according to TCFD requirements?
Sign up for free to unlockDoes XBiotech Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes XBiotech Inc disclose energy use targets?
Sign up for free to unlockDoes XBiotech Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes XBiotech Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for XBiotech Inc
These potential risks are based on the size, segment and geographies of the company.
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.